Background: Flavonoids are abundant plant phenolic compounds. More than 6000 have been identified to date, and some have been shown to possess antiparasitic activity. Here we investigate the effects of a range of common dietary flavonoids on the growth of two strains of the human malaria parasite Plasmodium falciparum.
Findings
Flavonoids are ubiquitous plant phenolic compounds that consist of two aromatic rings linked by a three-carbon bridge (see Table 1 for structure). More than 6000 flavonoids have been identified to date, and their essential functions in plants include regulating growth and providing protection against pathogens (reviewed in [1] ). They are currently attracting significant medical interest because of their antioxidant, antitumor, antiinflamma-tory, antimicrobial and antiviral activities. Flavonoids are present in fruits, vegetables, wine, tea and coffee. Estimates of the daily intake of flavonoids in developed countries are as high as 1-2 g [1] .
A number of reports have demonstrated growth inhibitory effects of flavonoids, particularly of the flavonol quercetin and of the flavone luteolin, on the protozoan parasite genera Toxoplasma [2] , Trypanosoma [3] and Leish-mania [4] [5] [6] . The majority of studies involving flavonoids and malaria describe the antiplasmodial activity-guided fractionation of plants (including species used in traditional medicine). Flavonoids (usually along with other compounds) have been identified in the antiplasmodial fractions of many plants, and in some cases have been shown to possess antiplasmodial activity when isolated [4, [7] [8] [9] [10] [11] [12] . Despite this, until very recently only the structurally distinct chalcone subclass of flavonoids attracted much further investigation.
In this study, the flavanone naringenin, the isoflavone genistein, and a range of flavonols (kaempferol, myricetin, quercetin and isoquercitrin) and flavones (acacetin, apigenin, baicalein, chrysin and luteolin) were tested against a chloroquine-sensitive (3D7) and a chloroquineresistant (7G8) strain of Plasmodium falciparum. The flavo-noids were purchased from Sigma-Aldrich (Australia), and purities were  95% except for isoquercitrin which was  90%. A recent study demonstrated the in vitro antiplasmodial activities of a number of these compounds [13] ; we confirm and extend these findings with different P. falciparum strains.
Of the eleven flavonoids tested, eight showed antiplasmodial activity against the 3D7 strain, with mean IC 50 values in the range 11-66 M ( Table 1 ). The remaining three (acacetin, naringenin and genistein) did not achieve 50% parasite killing at the highest concentrations tested (which varied according to solubility in aqueous media; DMSO concentrations were kept  0.1% to prevent any effect on parasite growth). All the flavonoids tested showed measurable activity against the chloroquine-resistant 7G8 strain, with IC 50 values between 12 and 76 M. The most Marked differences in the susceptibilities of the two strains to some flavonoids (most notably to acacetin) were observed in this study and in that of Tasdemir et al. [13] . In both studies, the chloroquine-resistant strain was generally more susceptible to growth inhibition. Whether enhanced sensitivity to some flavonoids relates to the chloroquine resistance phenotype or other difference(s) in genetic background is not known. These strain differences make structure-activity determinations difficult. Furthermore, potential differences in cell permeability should also be considered. The higher antiplasmodial activity of quercetin (logD 2.09) compared to the quercetin glucoside isoquercitrin (logD 1.59) (P = 0.002, paired t-test) could be a result of better cell permeability. Similarly, the flavanone naringenin (logD 2.17) differs from apigenin (logD 2.77) only in the absence of a double bond in the C ring but is much less active (P = 0.02, paired t-test for 7G8). Also, the isoflavone genistein (logD 1.53) differs from apigenin (logD 2.77) only in that the B ring is attached to carbon 3 of the C ring rather than carbon 2, and is less active against both strains (P = 0.03, paired t-test for 7G8). However, the testing of a number of additional flavonoids would be required to conclude that differences in activities are a result of different cell permeabilities.
The effect of a number of the flavonoids tested here on the viability of two normal (non-cancerous) human cell lines has been reported [14] . In the cases of apigenin, kaempferol, luteolin and quercetin, the IC 50 values against both strains of P. falciparum are at least 4-fold lower than the IC 50 values reported against both human cell lines. Naringenin has relatively low activity against P. falciparum (Table 1 ) and human cells [14] . In addition, Mamani-Matsuda et al. [3] investigated quercetin toxicity towards haemopoietic cells and found that the IC 50 value was greater than 100 M (> 6-fold higher than the IC 50 against P. falciparum reported here; Table 1 ).
To investigate which stage of the parasite's intraerythrocytic lifecycle is inhibited by flavonoids, we prepared Giemsa-stained 7G8-infected erythrocyte smears at various time points following the addition of 20 M luteolin (~2 × IC 50 ). Figure 1 reveals that luteolin does not inhibit the ring stage of the parasite but prevents the progression
The effect of luteolin on the intraerythrocytic growth of P. falciparum Figure 1 The effect of luteolin on the intraerythrocytic growth of P. falciparum. Giemsa-stained smears were prepared at 0, 19, 26 and 48 h after the addition of luteolin (20 M) dissolved in DMSO or an equal volume of DMSO (control; 0.025% DMSO) to 7G8-infected erythrocytes (1% parasitemia, 2% hematocrit). While control parasites developed into mature trophozoites (26 h) that subsequently gave rise to daughter parasites (48 h), the growth of luteolin-treated parasites was arrested at the young trophozoite stage. Luteolin-treated parasites did not give rise to daughter parasites, resulting in a reduced parasitemia compared to the control at the 48 h time point.
of parasite growth beyond the young trophozoite stage. The parasites are therefore unable to complete a full intraerythrocytic cycle. An arrest in cell cycle progression has also been observed for Leishmania donovani promastigotes treated with luteolin or quercetin [5] . Furthermore, quercetin has been shown to inhibit bradyzoite development in Toxoplasma gondii [2] . Further studies are required to elucidate the mechanism by which flavonoids arrest parasite growth.
There have been several reports of flavonoids showing synergistic or antagonistic activities with various antiparasitic drugs [10, 15, 16] . We therefore tested the effect of luteolin (at concentrations of 2.5 M, 5 M, 10 M and 20 M) on the susceptibility of 7G8 to two important antimalarial drugs, chloroquine and artemisinin. Luteolin did not significantly affect the IC 50 values of either drug (not shown). Therefore, luteolin should not antagonise the activities of chloroquine or artemisinin if used in combination therapy.
The finding that common dietary compounds display antiplasmodial activity raises the intriguing question of whether a plant-based diet could play a role in malaria prevention or lessen disease severity. To investigate whether combinations of dietary flavonoids could display an additive effect, we combined equimolar amounts of the eleven flavonoids tested in this study such that the highest concentration of each was not toxic to the parasite (4 M). This resulted in 50% growth inhibition against 7G8 at a total flavonoid concentration of 31 ± 3 M (Figure 2A) , a value similar to the mean IC 50 value for the eleven flavonoids (33 M). At this total flavonoid concen-tration, each individual flavonoid is present at a concentration of only 2.8 M. We then combined equimolar amounts of three of the most active compounds, luteolin, quercetin and apigenin, such that the highest total flavonoid concentration was 44 M (i.e. the same maximum total flavonoid concentration used when 11 flavonoids were combined). The combination of these three flavonoids gave an IC 50 value of 21 ± 2 M ( Figure 2B) , somewhat higher than their mean IC 50 value (13 M) . 
